$2 B revenue per year mark is not that far for CRUS. It may happen in 2016. Who thought SWKS will be at current levels? SWKS was struggling in $20s and now $100 is easy to get.
The action on semi, mostly is created by CNBC clowns. They point to China slow down but they are telling us that slow down will be for everything but not only phones.
Many US companies, from medical to consumer products, will be affected.
Now about AAPL and its products, AAPL watch is new and there will be several improved next generations.
Anyway, CRUS is not affected by watch sale number.
Now, QRVO is down 40% because it did not meet its estimates and its outlook is down.
SWKS is down 20% because it was traded at much higher PE than others in the group.
CRUS is down about the same as SWKS but the difference is CRUS was not trading at high PE and it did not miss but beat its estimates and raised its outlook. After all, CRUS is selling chips to other phone makers and it making progress in other part of its business.
So, CRUS has potential to go back to $40 in next few months and near future if it is not acquired by a company like QRVO, SWKS, AVGO, TXN, QCOM, BRCM or any company that is desperate for growth.
Unfortunately, SPPI is one of the losers.
Why does anyone take SPPI seriously?
tick, tick, short interest is up again.
IMGN is up 72% today because of just phase 1 of a cancer drug.
SPPI is waiting for approval of CE Mel and no one gives a rat's patoot.
You must be deaf, blind and no brain to not see why?
This scenario will be repeated over and over in near future.
The only thing that I can think is that SPPI bagholders are compulsive gamblers who enjoy losing money.
1- It is only drug in US that approved in past 30 years in CII Opioid space.
2- Only Opioid drug with dual purpose for pain, nociceptive and neuropathic pain.
3- A pain drug with low abuse profile and minimum side effect rate.
This can be a blockbuster pain drug and DEPO will make several billions out of this drug.